Trials / Completed
CompletedNCT02666807
Effects of Ginger Supplementation on NF-KB in Peripheral Blood Mononuclear Cells in Type 2 Diabetes Mellitus
Effects of Oral Ginger Supplementation on NF-KB (Nuclear Factor Kappa-light-chain-enhancer of Activated B Cells) in Peripheral Blood Mononuclear Cells (PBMC) and Glycemic and Lipid Profiles in Patients With Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Tehran University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 30 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the effect of ginger on NF-KB level in Peripheral Blood Mononuclear Cells in type 2 diabetic patients. Half of patients will receive ginger, while the other half will receive placebo.
Detailed description
ginger is a plant with lots of phytochemicals which have antioxidant effects. It reduces the NF-KB levels in the cells because of its antioxidant effects. It can reduces insulin resistance as a result of NF-KB reduction in diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Ginger | Ginger 500 mg capsules (2000 mg per day) by mouth twice daily (BID) for 10 weeks |
| DIETARY_SUPPLEMENT | placebo | Placebo matching with ginger 0 mg capsules by mouth twice daily (BID) for 10 weeks |
Timeline
- Start date
- 2015-06-01
- Primary completion
- 2015-11-01
- Completion
- 2015-11-01
- First posted
- 2016-01-28
- Last updated
- 2016-01-28
Source: ClinicalTrials.gov record NCT02666807. Inclusion in this directory is not an endorsement.